| The clinical trail of TRAIL EW Duiker, CH Mom, S De Jong, PHB Willemse, JA Gietema, ... European journal of cancer 42 (14), 2233-2240, 2006 | 251 | 2006 |
| CD103 defines intraepithelial CD8+ PD1+ tumour-infiltrating lymphocytes of prognostic significance in endometrial adenocarcinoma HH Workel, FL Komdeur, MCA Wouters, A Plat, HG Klip, FA Eggink, ... European journal of cancer 60, 1-11, 2016 | 142 | 2016 |
| Treatment regimen, surgical outcome, and T-cell differentiation influence prognostic benefit of tumor-infiltrating lymphocytes in high-grade serous ovarian cancer MCA Wouters, FL Komdeur, HH Workel, HG Klip, A Plat, NM Kooi, ... Clinical Cancer Research 22 (3), 714-724, 2016 | 84 | 2016 |
| CD103+ intraepithelial T cells in high-grade serous ovarian cancer are phenotypically diverse TCRαβ+ CD8αβ+ T cells that can be targeted for cancer immunotherapy FL Komdeur, MCA Wouters, HH Workel, AM Tijans, ALJ Terwindt, ... Oncotarget 7 (46), 75130, 2016 | 81 | 2016 |
| Molecular prognostic markers in ovarian cancer: toward patient-tailored therapy APG Crijns, EW Duiker, S De Jong, PHB Willemse, AGJ Van Der Zee, ... International Journal of Gynecologic Cancer 16 (Suppl 1), 2006 | 65 | 2006 |
| Enhanced antitumor efficacy of a DR5-specific TRAIL variant over recombinant human TRAIL in a bioluminescent ovarian cancer xenograft model EW Duiker, EGE De Vries, D Mahalingam, GJ Meersma, ... Clinical Cancer Research 15 (6), 2048-2057, 2009 | 63 | 2009 |
| The extrinsic apoptosis pathway and its prognostic impact in ovarian cancer EW Duiker, AGJ van der Zee, P de Graeff, W Boersma-van Ek, H Hollema, ... Gynecologic oncology 116 (3), 549-555, 2010 | 62 | 2010 |
| Biobanking of patient and patient-derived xenograft ovarian tumour tissue: efficient preservation with low and high fetal calf serum based methods NG Alkema, T Tomar, EW Duiker, G Jan Meersma, H Klip, ... Scientific reports 5 (1), 14495, 2015 | 56 | 2015 |
| Drug-induced caspase 8 upregulation sensitises cisplatin-resistant ovarian carcinoma cells to rhTRAIL-induced apoptosis EW Duiker, A Meijer, ARM van der Bilt, GJ Meersma, N Kooi, ... British journal of cancer 104 (8), 1278-1287, 2011 | 53 | 2011 |
| Integrative kinome profiling identifies mTORC1/2 inhibition as treatment strategy in ovarian clear cell carcinoma JJ Caumanns, K Berns, GBA Wisman, RSN Fehrmann, T Tomar, H Klip, ... Clinical Cancer Research 24 (16), 3928-3940, 2018 | 45 | 2018 |
| HER2 immunohistochemistry in endometrial and ovarian clear cell carcinoma: discordance between antibodies and with in‐situ hybridisation T Koopman, B van der Vegt, M Dijkstra, J Bart, E Duiker, GBA Wisman, ... Histopathology 73 (5), 852-863, 2018 | 26 | 2018 |
| Nuclear COMMD1 is associated with cisplatin sensitivity in ovarian cancer A Fedoseienko, HW Wieringa, GBA Wisman, E Duiker, AKL Reyners, ... PLoS One 11 (10), e0165385, 2016 | 20 | 2016 |
| Scoping review of clinical practice guidelines on the management of benign liver tumours MPD Haring, FJC Cuperus, EW Duiker, RJ de Haas, VE de Meijer BMJ Open Gastroenterology 8 (1), e000592, 2021 | 18 | 2021 |
| Development of a radioiodinated apoptosis–inducing ligand, rhTRAIL, and a radiolabelled agonist TRAIL receptor antibody for clinical imaging studies EW Duiker, ECF Dijkers, H Lambers Heerspink, S de Jong, ... British journal of pharmacology 165 (7), 2203-2212, 2012 | 18 | 2012 |
| Indeterminate pediatric acute liver failure: Clinical characteristics of a temporal cluster of five children in the Netherlands in the spring of 2022 WS Lexmond, VE de Meijer, R Scheenstra, STH Bontemps, EW Duiker, ... United European Gastroenterology Journal 10 (8), 795-804, 2022 | 17 | 2022 |
| Prognostic image-based quantification of CD8CD103 T cell subsets in high-grade serous ovarian cancer patients ST Paijens, A Vledder, D Loiero, EW Duiker, J Bart, AM Hendriks, ... Oncoimmunology 10 (1), 1935104, 2021 | 15 | 2021 |
| Behavior and complications of hepatocellular adenoma during pregnancy and puerperium: a retrospective study and systematic review MPD Haring, CS Spijkerboer, FJC Cuperus, EW Duiker, KP de Jong, ... Hpb 23 (8), 1152-1163, 2021 | 12 | 2021 |
| Intraoperative molecular fluorescence imaging of pancreatic cancer by targeting vascular endothelial growth factor: a multicenter feasibility dose-escalation study BGS Mulder, M Koller, EW Duiker, AF Sarasqueta, J Burggraaf, ... Journal of Nuclear Medicine 64 (1), 82-89, 2023 | 7 | 2023 |
| Development of radiolabeled mapatumumab and imaging in solid tumor patients who are treated with gemcitabine, cisplatin, and mapatumumab C Oldenhuis, EC Dijkers, EW Duiker, NL Fox, JL Klein, JA Gietema, ... Journal of Clinical Oncology 27 (15_suppl), e14521-e14521, 2009 | 6 | 2009 |
| A novel phenotype of a hepatocyte nuclear factor homeobox A (HNF1A) gene mutation, presenting with neonatal cholestasis AGM de Vries, WM Bakker-van Waarde, ACM Dassel, M Losekoot, ... Journal of Hepatology 63 (5), 1295-1297, 2015 | 4 | 2015 |
